This National Institute of Biomedical Imaging and Bioengineering (NIBIB) Project Grant award under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program supports the development of AI-assisted quantitative photon-counting-detector CT (PCD-CT) imaging techniques for improved cytogenetic risk prediction and treatment response monitoring in multiple myeloma patients. The $546,874 award, spanning Apr 2025 to Jan 2029, aims to create an imaging-based risk stratification model and derive quantitative PCD-CT biomarkers of bone marrow composition to better detect and manage multiple myeloma. The project leverages the capabilities of advanced PCD-CT imaging and AI algorithms to address limitations of current invasive diagnostic approaches and enable more comprehensive disease assessment across the whole skeleton. Mayo Clinic, the prime awardee, will collaborate on this effort to translate these innovative imaging technologies into clinical tools for improved multiple myeloma diagnosis, prognostication, and treatment monitoring.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $546.9k | 3/19/25 |